All Episodes
|
6
|
Dr. Allen Weiss

Episode 6 & 7: Behavioral Economics with Dr. Allen Weiss

May 17, 2018

Episode Summary

Dr. Allen Weiss, President and CEO of NCH Healthcare System, shares the importance of behavioral economics at NCH Healthcare System and Naples’ Blue Zones Project. This is Part 1 of 2.

Episode Notes

In this two-part podcast, John Marchica speaks with NCH Healthcare System’s president and CEO, Dr. Allen Weiss. Dr. Weiss breaks down how they have changed the mindset of community health at the health system level with astounding statistics and fruitful outcomes. Here are some of the highlights we cover:

Part 1 - 17 min.

  • Present day history of NCH Healthcare System
  • Focus on community health with Blue Zones project
  • Behavioral economics for reducing health care costs

Part 2 - 13 min.

  • Health System trends
  • Other health care systems going the same path as NCH Healthcare
  • Advice to new medical residents

Speaker Bios
Dr. Allen Weiss graduated from Columbia University’s College of Physicians and Surgeons and is board certified in Rheumatology, Internal Medicine, and Geriatrics. He is a Fellow of the American College of Physicians and the American College of Rheumatology. In 2017, Dr. Weiss became an Assistant Professor of Medicine at the Mayo Clinic School of Medicine and was also elected to the American Hospital Association Board. He’s been named to Becker’s Top 100 Outstanding Physician leaders of healthcare systems several times now.

John Marchica is a veteran health care strategist and CEO of Darwin Research Group. He was the founder and CEO of FaxWatch, a leading business intelligence and medical education company and two-time member of the Inc. 500 list of America's fastest growing companies. John is the author of The Accountable Organization and has advised senior management on strategy and organizational change for more than a decade. John earned his B.A. in economics from Knox College, an MBA and M.A. in public policy from The University of Chicago, and completed his Ph.D. coursework and doctoral exams in clinical epidemiology and health economics at The Dartmouth Institute for Health Policy and Clinical Practice. He is a faculty associate in the W.P. Carey School of Business and the College of Health Solutions at Arizona State University.

About Darwin Research Group
Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

CONNECT WITH US:

🌐 Visit us on the web

🌐 Follow Health Care Rounds on LinkedIn

🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media

Recommended Next

Podcast 197: Making Health Care Costs Simple and Transparent w/ Mark Cuban, Co-Founder, Cost Plus Drugs
Podcast 196: Physician Leadership in a New Era of Health Care w/ Dr. Sowmya Viswanathan, Baycare
Podcast 195: Why Primary Care Is Under Strain w/ Dr. Greg Whisman, Chief Medical Officer, CareMore Health
Podcast 194: Why Health Care Reform Keeps Failing w/ Dr. David Shulkin
Podcast 193: The New Model for Specialty Pharmacy w/ Jigar Thakkar, PharmD
Podcast 192: Making Value-Based Care Work at Scale w/ David Carmouche, MD
Podcast 191: Curing Nursing Burnout Through Education w/ Dr. Adele Webb
Podcast 190: The New Rules of Health System Leadership w/ John D’Angelo, MD, FACEP

Recommended Content

Browse Library
INsights
January 14, 2026

Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations

Read More
INsights
January 5, 2026

Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill

Read More
INsights
December 22, 2025

Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products

Read More
Stay Aware. Stay Informed.

Subscribe to Our Take

Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.